195 related articles for article (PubMed ID: 10432303)
1. cDNA cloning and characterization of guinea-pig leukotriene B4 receptor.
Masuda K; Yokomizo T; Izumi T; Shimizu T
Biochem J; 1999 Aug; 342 ( Pt 1)(Pt 1):79-85. PubMed ID: 10432303
[TBL] [Abstract][Full Text] [Related]
2. Cloning and characterization of rat leukotriene B(4) receptor.
Toda A; Yokomizo T; Masuda K; Nakao A; Izumi T; Shimizu T
Biochem Biophys Res Commun; 1999 Sep; 262(3):806-12. PubMed ID: 10471406
[TBL] [Abstract][Full Text] [Related]
3. Novel compounds that interact with both leukotriene B4 receptors and vanilloid TRPV1 receptors.
McHugh D; McMaster RS; Pertwee RG; Roy S; Mahadevan A; Razdan RK; Ross RA
J Pharmacol Exp Ther; 2006 Feb; 316(2):955-65. PubMed ID: 16207832
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the cloned guinea pig leukotriene B4 receptor: comparison to its human orthologue.
Boie Y; Stocco R; Sawyer N; Greig GM; Kargman S; Slipetz DM; O'Neill GP; Shimizu T; Yokomizo T; Metters KM; Abramovitz M
Eur J Pharmacol; 1999 Sep; 380(2-3):203-13. PubMed ID: 10513580
[TBL] [Abstract][Full Text] [Related]
5. Homologous desensitisation of the mouse leukotriene B4 receptor involves protein kinase C-mediated phosphorylation of serine 127.
Mollerup J; Eriksen HN; Albertsen J; Wulff T; Lambert IH; Hoffmann EK
Cell Physiol Biochem; 2007; 20(1-4):143-56. PubMed ID: 17595524
[TBL] [Abstract][Full Text] [Related]
6. Endothelium-dependent vascular responses induced by leukotriene B4.
Bäck M; Sakata K; Qiu H; Haeggström JZ; Dahlén SE
Prostaglandins Other Lipid Mediat; 2007 May; 83(3):209-12. PubMed ID: 17481557
[TBL] [Abstract][Full Text] [Related]
7. A novel hepatointestinal leukotriene B4 receptor. Cloning and functional characterization.
Wang S; Gustafson E; Pang L; Qiao X; Behan J; Maguire M; Bayne M; Laz T
J Biol Chem; 2000 Dec; 275(52):40686-94. PubMed ID: 11006272
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo pharmacological characterization of BIIL 284, a novel and potent leukotriene B(4) receptor antagonist.
Birke FW; Meade CJ; Anderskewitz R; Speck GA; Jennewein HM
J Pharmacol Exp Ther; 2001 Apr; 297(1):458-66. PubMed ID: 11259574
[TBL] [Abstract][Full Text] [Related]
9. Leukotriene B4 signaling through NF-kappaB-dependent BLT1 receptors on vascular smooth muscle cells in atherosclerosis and intimal hyperplasia.
Bäck M; Bu DX; Bränström R; Sheikine Y; Yan ZQ; Hansson GK
Proc Natl Acad Sci U S A; 2005 Nov; 102(48):17501-6. PubMed ID: 16293697
[TBL] [Abstract][Full Text] [Related]
10. A second leukotriene B(4) receptor, BLT2. A new therapeutic target in inflammation and immunological disorders.
Yokomizo T; Kato K; Terawaki K; Izumi T; Shimizu T
J Exp Med; 2000 Aug; 192(3):421-32. PubMed ID: 10934230
[TBL] [Abstract][Full Text] [Related]
11. Leukotriene binding, signaling, and analysis of HIV coreceptor function in mouse and human leukotriene B4 receptor-transfected cells.
Martin V; Ronde P; Unett D; Wong A; Hoffman TL; Edinger AL; Doms RW; Funk CD
J Biol Chem; 1999 Mar; 274(13):8597-603. PubMed ID: 10085095
[TBL] [Abstract][Full Text] [Related]
12. Molecular cloning and characterization of another leukotriene B4 receptor.
Kamohara M; Takasaki J; Matsumoto M; Saito T; Ohishi T; Ishii H; Furuichi K
J Biol Chem; 2000 Sep; 275(35):27000-4. PubMed ID: 10889186
[TBL] [Abstract][Full Text] [Related]
13. Pharmacologic actions of the second-generation leukotriene B4 receptor antagonist LY293111: in vitro studies.
Jackson WT; Froelich LL; Boyd RJ; Schrementi JP; Saussy DL; Schultz RM; Sawyer JS; Sofia MJ; Herron DK; Goodson T; Snyder DW; Pechous PA; Spaethe SM; Roman CR; Fleisch JH
J Pharmacol Exp Ther; 1999 Jan; 288(1):286-94. PubMed ID: 9862783
[TBL] [Abstract][Full Text] [Related]
14. Isolation and properties of platelet-activating factor receptor cDNAs.
Nakamura M; Honda Z; Matsumoto T; Noma M; Shimizu T
J Lipid Mediat; 1993; 6(1-3):163-8. PubMed ID: 8395240
[TBL] [Abstract][Full Text] [Related]
15. Differential inhibition of receptor activation by two mouse monoclonal antibodies specific for the human leukotriene B4 receptor, BLT1.
Sabirsh A; Pettersson A; Boketoft A; Kotarsky K; Owman C
Int Immunopharmacol; 2003 Dec; 3(13-14):1829-39. PubMed ID: 14636832
[TBL] [Abstract][Full Text] [Related]
16. Subcellular localization of leukotriene receptors in human endothelial cells.
Johansson AS; Haeggström JZ; Hultenby K; Palmblad J
Exp Cell Res; 2010 Oct; 316(17):2790-6. PubMed ID: 20688055
[TBL] [Abstract][Full Text] [Related]
17. The molecular characterization and tissue distribution of the human cysteinyl leukotriene CysLT(2) receptor.
Takasaki J; Kamohara M; Matsumoto M; Saito T; Sugimoto T; Ohishi T; Ishii H; Ota T; Nishikawa T; Kawai Y; Masuho Y; Isogai T; Suzuki Y; Sugano S; Furuichi K
Biochem Biophys Res Commun; 2000 Aug; 274(2):316-22. PubMed ID: 10913337
[TBL] [Abstract][Full Text] [Related]
18. 5-Lipoxygenase products regulate basophil functions: 5-Oxo-ETE elicits migration, and leukotriene B(4) induces degranulation.
Iikura M; Suzukawa M; Yamaguchi M; Sekiya T; Komiya A; Yoshimura-Uchiyama C; Nagase H; Matsushima K; Yamamoto K; Hirai K
J Allergy Clin Immunol; 2005 Sep; 116(3):578-85. PubMed ID: 16159627
[TBL] [Abstract][Full Text] [Related]
19. Leukotriene B4 is an indirectly acting vasoconstrictor in guinea pig aorta via an inducible type of BLT receptor.
Bäck M; Qiu H; Haeggström JZ; Sakata K
Am J Physiol Heart Circ Physiol; 2004 Jul; 287(1):H419-24. PubMed ID: 15016629
[TBL] [Abstract][Full Text] [Related]
20. Expression, purification and characterization of leukotriene B(4) receptor, BLT1 in Pichia pastoris.
Hori T; Sato Y; Takahashi N; Takio K; Yokomizo T; Nakamura M; Shimizu T; Miyano M
Protein Expr Purif; 2010 Jul; 72(1):66-74. PubMed ID: 20188179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
